{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/157332641"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "NSI-189, the lead compound in Neuralstem's small molecule platform, is a proprietary new chemical entity that stimulates new neuron growth in the hippocampus, a region of the brain believed to be implicated in MDD as well as other diseases and conditions, such as chronic traumatic encephalopathy (CTE), Alzheimer's disease, anxiety, and post-traumatic stress disorder (PTSD)." ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "bio-medicine.org" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/193012238"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/157332641" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/261800807"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/157332641"] } } }
